BCL2 inhibition in acute and chronic pancreatitis - is there a therapeutic perspective?

Litewka JJ, Jakubowska MA, Huang W, Ferdek PE

Open source

DOI
10.1038/s41420-026-03179-8
Published
2026 May 30
Container
Cell death discovery
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41420-026-03179-8,
  title = {BCL2 inhibition in acute and chronic pancreatitis - is there a therapeutic perspective?},
  author = {Litewka JJ and Jakubowska MA and Huang W and Ferdek PE},
  year = {2026},
  journal = {Cell death discovery},
  doi = {10.1038/s41420-026-03179-8},
  url = {https://doi.org/10.1038/s41420-026-03179-8}
}

RIS

TY  - JOUR
TI  - BCL2 inhibition in acute and chronic pancreatitis - is there a therapeutic perspective?
AU  - Litewka JJ
AU  - Jakubowska MA
AU  - Huang W
AU  - Ferdek PE
PY  - 2026
JO  - Cell death discovery
DO  - 10.1038/s41420-026-03179-8
UR  - https://doi.org/10.1038/s41420-026-03179-8
ER  - 

APA

JJ, L., MA, J., W, H., & PE, F. (2026). BCL2 inhibition in acute and chronic pancreatitis - is there a therapeutic perspective?. Cell death discovery. https://doi.org/10.1038/s41420-026-03179-8

Source records